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Introduction
Blood transfusion and blood conservation (techniques or
strategies to avoid the need for blood) are
complementary activities that constitute the clinical
arena of transfusion medicine. Recent improvements in
the safety of the blood supply and the increasing costs
associated with transfusion therapies have led to a re-
evaluation of the clinical practices of blood transfusion
and blood conservation.
Among the issues that have been re-evaluated are the
threshold for transfusion at which the benefits outweigh
the risks and the identification of patients most likely to
benefit from blood conservation.1
Historically, haemoglobin concentration or haematocrit
value at which physicians transfuse allogeneic blood
products during acute anaemia, that is, the transfusion
trigger or threshold, has been 100g/L or 30%.2-7 Plasma
transfusions to correct coagulation abnormalities (and in
the past, to expand intravascular volume) have also been
guided by standard protocols and specific triggers rather
than an assessment of the individual patient's overall
risks and benefits. Since 1985, concerns about the
transmission of human immunodeficiency virus (HIV)
and other viruses through blood products have
significantly modified both real and perceived risks and
benefits. Many agencies have responded by issuing
clinical practice guidelines (CPGs) advocating a more
restrictive approach to the use of allogeneic red blood
cells (RBCs) and plasma.6-10
Transfusion practices have been shown to vary
substantially between hospitals, within clinical settings,
within specific disease categories and surgical procedures
independent of patient characteristics. International
estimates of inappropriate RBC transfusion range from
16% to 66%. So far, there are no absolute guidelines
available to facilitate the decision of transfusion and thus
the practice remains flexible with varying threshold for
transfusion. The use of algorithms and implementation of
educational programmes have proven to be effective in
modifying the conduct and beliefs of physicians in
relation to transfusion. Nevertheless, randomised
controlled studies that provide evidence-based data are
needed for future transfusion practice.**22-24World Health
Organisation (WHO) guidelines suggest that transfusion is
indicated with haemoglobin level <7gm/dl, and not
needed with value >10gm/dl. However, what falls
between these two limits is the starting point of
controversy.
The aim of current study was to assess the
appropriateness of transfusion at orthopaedic floor in
terms of its compatibility with the available guidelines
and to standardise the practice of transfusion. 
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Abstract
Objectives: To determine the proportion of inappropriate transfusions in patients undergoing orthopaedic surgery
at a tertiary care university hospital, and factors associated with inappropriate transfusions.
Methods: The prospective study was conducted at Aga Khan University Hospital, Karachi, from December 2008 to
September 2009, and comprised patients admitted to the Orthopaedic Department and received transfusion of at
least one packed cell. Patients were divided into four groups: A, those with haemoglobin < 7, B, haemoglobin 7.1-10
without ischemic heart disease, C, haemoglobin 7.1-10 with ischemic heart disease, and D, haemoglobin >10.
Variables recorded were, pre-transfusion haemoglobin level, co-morbids, symptoms of hypovolemia, pre-
transfusion volume replacement with fluids, transfusion reactions, and haemoglobin after 48 hours. Indications of
transfusion were assessed in accordance with available data.
Results: Of the 126 patients, 65(52%) were males and 61(48%) were females. There were 18(14%) patients in group
A, 88(70%) in group B, 12(10%) in group C, and 8(6%) in group D. Overall, Overall, 44(35%) were transfused
appropriately according to the criteria, and 82(65%) were inappropriate.
Conclusion: The number of inappropriate transfusion was quiet high and demands revision of institutional policy
of packed cell transfusion in accordance with available guidelines.
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Patients and Methods
The prospective study was conducted from December
2008 to September 2009 at Aga Khan University Hospital,
Karachi, and comprised patients who were admitted to
Orthopaedic Department and received transfusion
irrespective of initial trauma or the postoperative day. All
patients who were transfused at least 1pnt of PRBC were
included. Those who received preoperative transfusions
and all transfusions other than RBCs were excluded. The
patients were divided into four groups: A, those with
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Annexure-1: Guidelines for Canadian Clinical Practice, Ottawa, Canadian Medical Association (1994).
haemoglobin < 7, B, haemoglobin 7.1-10 without
ischemic heart disease, C, haemoglobin 7.1-10 with
ischemic heart disease, and D, haemoglobin >10.
Data was collected through a specifically designed
questionnaire which was filled out concurrently as the
patients were transfused by on-call duty doctor. They
were first familiarised with the questionnaire and
information was collected until the patient was
discharged from the Orthopaedic service.
Variables recorded were demographic details like age,
gender, date and duration of hospitalisation, mode of
admission (emergency or elective), type of surgery, pre-
transfusion haemoglobin level, American Society of
Anesthesiologists (ASA) level, co-morbids, signs and
symptoms of hypovolemia (like weakness, vertigo,
syncope, tachycardia, angina, dyspnoea, mental status
change), pre-transfusion volume replacement with fluids,
pre-transfusion vitals, transfusion reactions and
haemoglobin after 48 hours. Indications of transfusion
were assessed in accordance with available data. We also
noted the consultant under whose supervision the
patient was admitted and who ordered the transfusion.
We compared our transfusion practices with the
guidelines of the Guidelines for Canadian Clinical Practice,
Ottawa, Canadian Medical Association, 1994 (Annexure-
1). It is a set protocol of indications for transfusions,
According to the guidelines, if the acute blood loss is
>20% regardless of haematocrit, the patient needs
transfusion. If there is no acute blood loss, consider
haematocrit; if its >30% no need for transfusion, but if
<30% then transfuse if the  patient is at the risk of
ischemia which include age >65, history of chronic heart
failure  (CHF) or coronary artery disease (CAD), stroke or
transient ischemic attack (TIA) or history of heart valve
disease. If the patient is not at the risk of ischemia then in
comes the age and haematocrit (Hct) criteria which is age
<40 Hct <24 % (If patient is healthy and can tolerate lower
haematocrit) age 40-65, Hct <27% age >65, Hct <30 % if
no, then no transfusion, but, if yes, then check if the
patient has signs and symptoms of acute anaemia which
are syncope  tachycardia (older than 40 yrs, heart rate(HR)
>100, younger than 40, HR>120) Angina/Dyspnaea  Pulse
oximetry <90% or arterial blood gas (PaO2) <70 mmHg,
Mental status change, if yes, then transfuse, if no, then no
transfusion is required.11-19
We also compared our data with British Task Force
recommendations20 which consider need based on
estimation of lost blood volume and on haemoglobin
concentration (Annexure-2).
It is expensive to collect, process and administer. One pint
of blood costs about 120 Pounds in Britain  and 19.2 British
Pounds in Pakistan  (Rs.2700 approximately)21 and so it calls
for rational use of blood transfusion which means getting
the right blood to the right patient at the right time.
After each transfusion, it was categorised as adequate
or inadequate according to these established criteria.
Nevertheless, randomised controlled studies that provide
evidence-based data are needed for future transfusion
practice.22-24
For statistical analysis, SPSS 17 was used.
Results
Of the 126 patients, 65(52%) were males and 61(48%)
females. Overall, 12(10%) patients had prior IHD and
4(3%) had a pulmonary problem. There were 18(14%)
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Annexure-2: British committee for standards in heamatology recommendations.34
Need based on estimation of lost blood volume
>40% loss (>2000ml)
Rapid volume replacement including RBC transfusion is required
30% to 40% loss (1500ml to 2000ml)
Rapid volume replacement with crystalloids or synthetic colloids is required, RBC
transfusion may also be needed
15% to 30% loss (800ml to 1500ml)
Need to transfuse crystalloids or synthetic colloids;need for RBC transfusion is unlikely
unless the patient has pre-existing anemia,continuing blood loss or reduced
cardiovascular reserves.
Less than 15% blood loss(<750 ml)
No need for transfusion unless volume loss is superimposed on preexisting anemia or
when patient is unable to compensate due to severe cardiac or respiratory disease.
Need based on Hb concenteration
Hb < 7g/dl
RBC transfusion indicated.If the patient is otherwise stable the patient should receive 2
units of packed RBCs following which the patient clinical status and Hb should be
reassessed.
Hb 7-10 g/dl
Correct strategy is unclear
Hb> 10 g/dl
RBC transfusion not indicated
High risk patients
Patients > 65 yrs of age and/or those with cardiovascular or respiratory disease may
tolerate anemia poorly. Such patients should be transfused when Hb < 8 g/dl.
Table-1: Gender ratio.
Variables Appropriate Inappropriate P-value
Sex
Male 24 41 0.075
Female 20 41
patients in group A, 88(70%) in group B, 12(10%) in group
C, and 8(6%) in group D. 
Overall, 44(35%) were transfused appropriately according
to the criteria, and 82(65%) were inappropriate (Table-1).
There were 44(35%) ASA 1, 53(42%) ASA 2 and 29(23%)
ASA 3 patients. Overall, 75(59.5%) patients were
transfused for the 1st time. Four (3%) patients
encountered transfusion reactions, while 24(19%)
patients had some clinical indication of transfusion,
including hypotension and tachycardia (Table-2).
Pre-transfusion vitals showed 4(3%) had fever, 25(20%)
had tachycardia and 2(1.6%) were tachypneaic and
7(5.5%) were hypotensive (Table-3).
Pre-transfusion Hb, IHD and co-morbid statuses of the
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Table-2: Division of patients according to American Society of Anesthesiologists (ASA)
grading, previous transfusions, reactions and clinical indications. 
Variables Patients
ASA
I 44
II 53
III 29
Previous Transfusions
Yes 31
No 75
Transfusion Reactions
Yes 4
No 122
Clinical Indications
Yes 24
No 102
Table-3: Vital signs.
Variable Patients
Temperature
Normal 122
Fever 4
Pulse
Tachycardia 25
Bradycardia 1
Normal 100
Respiratory Rate
Normal 124
Tachypnea 2
Blood Pressure
Normotensive 115
Hypertensive 4
Hypotensive 7
Table-7: Estimated blood loss values.
Blood Volume (ml) No of Patients
250 66
500 31
750 11
1000 14
>1000 04
Table-8: Day on which blood transfusion was done.
Post-op Day No of Transfusion
0 4
1 80
2 28
3 4
After day 3 10
Table-4: Pre-transfusion haemoglobin status.
Frequency Percent Valid Percent Cumulative Percent
Valid <7 18 14.3 14.3 14.3
7.1-10 100 79.4 79.4 93.7
>10 8 6.3 6.3 100.0
Total 126 100.0 100.0
Table-5: Pre-transfusion haemoglobin and ischemic heart disease status.
Frequency Percent Valid Cumulative
Percent Percent
Valid <7 18 14.3 14.4 14.4
7.1-10 without IHD 88 69.8 70.4 84.8
7.1-10 with IHD 11 8.7 8.8 93.6
>10 8 6.3 6.4 100.0
Total 125 99.2 100.0
Missing System 1 0.8
Total 126 100.0
Table-6: Co morbid.
Frequency Percent Valid Percent Cumulative Percent
Diabetes Mellitus
Valid Yes 23 18.3 18.3 18.3
No 103 81.7 81.7 100.0
Total 126 100.0 100.0
Hypertension
Valid Yes 38 30.2 30.2 30.2
No 88 69.8 69.8 100.0
Total 126 100.0 100.0
patients were also noted (Tables-4-6).
Estimated blood loss, as assessed intraoperatively, was
250ml in 66(52%) patients, and 500ml in 31(25%)
(Table-7). 
Besides, 4(3%) patients were transfused on the day of
surgery (Table 8). Volume of blood transfused were also
noted (Table-9).
There were 18(14%) patients who had Hb <7 and were
transfused . Nine (7%) patients had Hb >10; 11(9%) had 7-
10 with some co-morbid, while 88(70%) had Hb in 7-10
didn't have any comorbid yet they were transfused (Figure).
The practice pattern of different consultants were also
seen which were arbitrary based on random criteria
(Table-10).
Discussion
Blood transfusion is the process of transferring blood or
blood-based products from one person into the
circulatory system of another. It is life-saving in some
situations as in acute haemorrhagic shock. Transfusions
are also needed to replace blood lost during surgery.
Blood transfusion though life-saving is not without risks
or costs. Nevertheless, there is no consensus as to the
precise indications for the use of this treatment and there
is evidence of significant variations in transfusion practice.
These variations do not correlate with the characteristics
of the patients and depend more on the individual criteria
of the attending physician; a fact that suggests extensive
inappropriate transfusion use.25-27 The risks of
transmitting numerous blood-borne diseases cannot be
emphasised more. Safe blood is a scarce and valuable
resource. And, hence, the need for more vigilant use of it.
In literature, the rates of appropriate transfusion practice
vary enormously (from 3% to 42.3%) because of marked
differences in the criteria used to assess this clinical
activity.27-30 We found that most episodes of
inappropriate use occurred as a result of overestimating
the patient's immediate risk. Other studies have described
a higher rate of inappropriate transfusion practice in
surgery departments than in other medical specialities.
It is expensive to collect, process and administer. One pint
of blood costs about 120 Pounds in Britain  and 19.2
British Pounds in Pakistan  (Rs.2700 approximately)21 and
so it calls for rational use of blood transfusion which
means getting the right blood to the right patient at the
right time. Limiting transfusions to patients whose chance
of survival or quality of life is improved with blood will
help to decrease the high demand for blood products and
will reduce unnecessary exposure of patients to the risks
of transfusion. The unnecessary expenditure implicated in
inappropriate PRBC transfusion implies a loss of capacity
to meet other healthcare needs that might be beneficial
to patients. Along this line, an important problem is the
difficulty with which physicians assume the concept of
cost-opportunity. The extended idea is that physicians
should do what they think is best for the patient without
other considerations. Nevertheless, this does not take into
account the fact that when limited resources are involved,
excessive attention to one patient may result in
inadequate attention to another and may lead to
inefficacy.28-31
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Table-9: Amount of pints transfused.
Pints No of Patients
1 61
2 48
3 8
>3 9
Table-10: Consultants' Practice patterns realted to transfusions.
Consultants Appropriate Inappropriate
A 09 04
B 01 00
C 29 07
D 23 16
E 07 03
F 05 08
G 08 06
Figure: Haemoglobin status and transfusion.
The reasons for inappropriate use of this resource will be
the subject of future investigation, but it is likely that the
following will be among them: first, many physicians may
be unaware that transfusion guidelines exist, and even if
they know about them, they may not have sufficient
knowledge of the specific situations in which transfusion
is indicated; second, current trends in medical practice
can result in overtreatment, particularly in cases of acute
bleeding or in patients undergoing procedures in which
the technical characteristics favour substantial bleeding;
and, third, it is a fact that the available clinical guidelines
for PRBC transfusion are not based on grade-A evidence in
an age when evidence-based medicine is becoming the
norm.31-33
General guidelines for appropriate transfusion practice
include WHO recommendations which suggest that all
donated blood should be tested for HIV, acquired
immunodeficiency syndrome (AIDS) hepatitis, syphilis
and malaria. Decision to transfuse must be based on
hematologic and clinical status of the patient and
patient's risks for developing complications of inadequate
tissue-oxygen delivery.
There are many complications associated with blood
transfusions which include allergic reactions,  transfusion-
related acute lung injury (TRALI), delayed haemolytic
transfusion reaction, febrile non-haemolytic transfusion
reaction, Graft vs. Host disease infections, and
complications of massive transfusions.34
Different protocols are there for transfusion of blood
products in different parts of the world. There are many
controversies regarding blood transfusions, different
criteria of assessing blood loss. Different protocols and
threshold of transfusions are not only variable among
different regions of the world, but even among different
consultants of the same centre.
There was no gender-wise discrimination for transfusion.
Approximately same number of males and females were
inadequately transfused and the p value was also not
significant. ASA level also had no significance though
indirectly it should have as the more patient has co-
morbid the lower the threshold of transfusion, and more
the ASA value, more chances are there for these patients
to be transfused. This was not the case with our patients
as the p-value came out to be non-significant.
Clinical judgment also plays a significant role in deciding
which patients to be transfused. Vitals, especially blood
pressure and pulse, are very important in this regard. It
was seen that only 24 patients had clinical symptoms of
blood transfusion out of 126, showing total disregard to
clinical judgment in addition to laboratory values.
Estimated blood loss also plays an important role in
decision-making about blood transfusion. According to
the British Committee for Standards in Haematology,35
acute blood loss of >40% or >2000ml requires rapid blood
transfusion, while 15% loss of about 750ml needs no
transfusion. In our study, there were 29 patients who had
blood loss of 750ml or more and needed transfusion
according to these guidelines, while 97 patients had a loss
less than 750ml yet they were transfused.
Most of the patients (80) were transfused on 1st post-op
day, most probably due to the practice of checking
haemoglobin on 1st post-op day and then making the
decision to transfuse. This post-op day was not a standard
time after surgery, like it varied from 4hr to 18hrs
depending upon the time of the day surgery ended. Due
to this the reason for decreased Hb cannot be
distinguished that whether it is due to the actual blood
loss or dilutional decrease in Hb.
Recent literature also shows that there is no role of just 1
pint of blood transfusion, but in our study about half of
the patients (61) were transfused 1 pint of blood.
We also concluded that 18(14%) patients had Hb <7 and
were fulfilling the criteria for transfusion, while 9 patients
had Hb of >10 and were unnecessarily transfused.
Besides, 11 patients had Hb 7-10 and these patients had
IHD as a co-morbid. Hence, they had a relative transfusion
indication while a bulk of patients (70%) had the same Hb
while not having any co-morbid but were still  transfused
which could have been clearly avoided. Many of the
patients had their 1st transfusion and that too
unnecessarily.
Individually, transfusion practices of all the consultants
were analysed and it was found that the consultants had
ordered unnecessary transfusions more than the
indicated one and each having their own personal
threshold. Interestingly, this is the only variable which
came out significant (p<0.05).
It was estimated that every third patient admitted in the
Orthopaedics Department had undergone blood
transfusion whether appropriate or inappropriate. This
shows the amount of burden on the acquiring,
processing, storing and utilisation of this valuable source.
Segregating adequate transfusions from inadequate ones
decreased that number from 1 in 3 to 1 in 20, meaning
that from 33% transfusion rate it dropped to 5% of the
admitted patients. So, just by adhering to the guidelines,
the need for transfusion can be drastically reduced and
the pressure on this precious resource can be decreased.
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Conclusion
The numbers of inappropriate transfusion was quiet high
and demands revision of institutional policy of packed cell
transfusion in accordance with available guidelines.
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